EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Restoring Sight: The Journey of AIPL1 from Discovery to Therapy

Alima Galieva iD, Alexander Karabelsky iD, Alexander D Egorov iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262412066 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alima Galieva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gene Therapy Department, Center for Translational Medicine, Sirius University of Science and Technology, 354340 Sirius, Russia. Hauptthemen laut MEDLINE: Leber Congenital Amaurosis, Eye Proteins, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leber congenital amaurosis (LCA) is a severe inherited retinal disorder manifesting at birth or in early infancy, with a subset of cases linked to mutations in the aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) gene. Initially identified as the disease locus for LCA4, AIPL1 exhibits a retina-specific expression pattern. Its protein product is a unique member of the FKBP family, distinguished by its specific structural features and specialized functions. A wide spectrum of mutations in AIPL1 is associated with varying severities of retinal degeneration, implicating diverse pathogenic mechanisms. While the early onset and rapid progression of AIPL1-related disorders pose a therapeutic challenge, significant progress in gene therapy has unlocked promising avenues for effective treatment. This comprehensive review summarizes current findings to spark interest and pave the way for further studies in the therapy of AIPL1-caused retinal diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leber Congenital AmaurosisEye ProteinsAdaptor Proteins, Signal TransducingHumansGenetic TherapyAnimalsMutationRetinal Degeneration

Stichwörter der Autor:innen

AIPL1Leber congenital amaurosisLeber congenital amaurosis type 4adeno-associated virusaryl hydrocarbon receptor interacting proteinaryl hydrocarbon receptor interacting protein-like 1gene therapyinherited retinal diseasesphotoreceptorsvision

Substanzen

Eye ProteinsAIPL1 protein, humanAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Gene Therapy Department, Center for Translational Medicine, Sirius University of Science and Technology, 354340 Sirius, Russia.

ORCID-Profile: Alima Galieva, Alexander Karabelsky, Alexander D Egorov

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Galieva, A., Karabelsky, A., & Egorov, A. D. (2025). Restoring Sight: The Journey of AIPL1 from Discovery to Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262412066

Vancouver

Galieva A, Karabelsky A, Egorov AD. Restoring Sight: The Journey of AIPL1 from Discovery to Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262412066

BibTeX
@article{Galieva2025,
  author = {Galieva, Alima and Karabelsky, Alexander and Egorov, Alexander D},
  title = {Restoring Sight: The Journey of AIPL1 from Discovery to Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262412066}
}
Kostenlos starten →